Is fever a contraindication to administering the anti‑rabies vaccine Rabipur (human diploid cell rabies vaccine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fever is NOT a Contraindication to Rabipur for Postexposure Prophylaxis

For postexposure rabies prophylaxis, there are no contraindications to administering Rabipur, including the presence of fever, because rabies is almost invariably fatal once symptoms develop. 1

Contraindications by Clinical Context

Postexposure Prophylaxis (After Potential Rabies Exposure)

  • No contraindications exist for postexposure prophylaxis, including fever, pregnancy, or any other medical condition. 1
  • The FDA label explicitly states: "In view of the almost invariably fatal outcome of rabies, there is no contraindication to postexposure prophylaxis." 1
  • Given the 100% mortality rate of clinical rabies, the risk-benefit calculation always favors vaccination regardless of concurrent illness. 1

Preexposure Prophylaxis (Preventive Vaccination)

  • Only a history of anaphylaxis to the vaccine or any vaccine component constitutes a contraindication to preexposure vaccination. 1
  • Fever alone is not listed as a contraindication even for preexposure prophylaxis. 1

Management of Fever During Vaccination

  • Fever is a commonly reported adverse reaction to Rabipur, occurring uncommonly (temperatures above 38°C/100°F). 1
  • If fever develops after vaccination, it can be successfully managed with antipyretic agents without interrupting the vaccine series. 1
  • Once rabies prophylaxis is initiated, it should not be interrupted or discontinued because of local or mild systemic adverse reactions, including fever. 1

Critical Clinical Principles

  • The vaccine schedule must be completed as recommended: days 0,3,7,14, and 28 for previously unvaccinated individuals receiving postexposure prophylaxis. 2, 3
  • Minor delays of a few days for individual doses are acceptable, but the series should not be abandoned due to intercurrent illness. 2, 3
  • Human rabies immune globulin (HRIG) must be administered on day 0 along with the first vaccine dose for all previously unvaccinated individuals. 3

Common Pitfalls to Avoid

  • Do not defer or withhold postexposure prophylaxis due to fever or any other medical condition—rabies mortality is essentially 100%. 1
  • Do not confuse preexposure and postexposure contraindications; the latter has none. 1
  • Do not discontinue the vaccine series if fever develops as an adverse reaction; manage symptomatically with antipyretics. 1
  • Seek advice from state health departments or CDC only for management of serious adverse reactions (e.g., anaphylaxis, neurological events), not for common reactions like fever. 1

References

Guideline

Rabies Post‑Exposure Prophylaxis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.